Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Shaffiq Essajee spoke during today’s plenary session about HIV prevention and treatment for children with a strong focus on the treatment side. “While we are seeing 60 […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Professor David Cooper kicked off the final opening plenary in Melbourne today with a review on antiretroviral therapy including a look at recommended drug regimens for first- […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Activists surprised Gilead corporate executives today with a “die-in” to protest the pricing of Gilead’s hepatitis C drug, Solvaldi (sofosbuvir). As Gregg Alton, Gilead’s Executive Vice-President […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Laurindo Garcia, a gay man living with HIV in the Philippines offered a moving conclusion to the opening plenary In Melbourne on Thursday, speaking to […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – During the opening plenary today, Beatriz Grinszteijn offered insights about men with have sex with men and transgender women echoing many of the themes raised in […]
HIV
The science is clear, HIV criminalization is abusive, discriminatory and counterproductive – The destructiveness of HIV-specific laws that fueled stigma and discouraged diagnosis by criminalizing people […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
A look at how measles comes into the United States highlights needs for both more vigilant vaccination efforts, and support for global efforts to eliminate the […]